1-4 of 4
Andreas Lammerich
Close
Sort by
Journal Articles

A Phase 2, International, Multicenter, Prospective Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients with Solid Tumors Undergoing Chemotherapy

Noah Federman, Monica Desiree Dragomir, Zoryana Kizyma, Vladimir Lebedev, Jelena Roganovic, Peter Bias, Andreas Lammerich, Zipi Roth-Ben Arie, Linglong Zou, Anton Buchner
Journal: Blood
Blood (2017) 130 (Supplement 1): 2271.
https://doi.org/10.1182/blood.V130.Suppl_1.2271.2271
Published: 2017
Journal Articles

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Camille N Abboud, Nicole Lang, Andreas Lammerich, Anton Buchner, Patrick Liu, Udo Mueller, Ashutosh Pathak
Journal: Blood
Blood (2016) 128 (22): 2504.
https://doi.org/10.1182/blood.V128.22.2504.2504
Published: 2016
Journal Articles

Pegylated Versus Glycopegylated G-CSFs and Their Biochemical and Physiological Properties

Afsaneh Abdolzade-Bavil, Bridget A. Cooksey, Christian Scheckermann, Andreas Lammerich, Laurie Pukac, Philip Krasney, Hermann Allgaier, Wenyan David Shen, Udo Müller, Patrick Liu, Aaron von Kerczek
Journal: Blood
Blood (2013) 122 (21): 4851.
https://doi.org/10.1182/blood.V122.21.4851.4851
Published: 2013
Journal Articles

Evaluation Of Electrocardiogram Parameters In Patients With Breast and Lung Cancer Treated With Chemotherapy and Lipegfilgrastim Or Pegfilgrastim

Andreas Lammerich, Igor Bondarenko, Udo Müller
Journal: Blood
Blood (2013) 122 (21): 4856.
https://doi.org/10.1182/blood.V122.21.4856.4856
Published: 2013